Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery (II)
Weill Cornell Medicine, Cardiothoracic Surgery
Weill Cornell Medicine
New York, New York, United States
Dr. Gaudino completed his undergraduate studies and earned his medical degree in Rome, Italy at the University of Rome, Faculty of Medicine and Surgery in 1994. He subsequently completed his residency in 1999 at the same University and joined the faculty there in 2000 where he remained until 2014, when he joined the Department of Cardiothoracic Surgery at Weill Cornell Medicine. He completed an Advanced Cardiovascular/Aortic Aneurysm Surgery Fellowship in 2016 and was recruited to stay on staff as Assistant Professor of Cardiothoracic Surgery. In 2017, he was elevated to the position of Professor in Cardiothoracic Surgery and Attending Cardiothoracic Surgeon at NY-Presbyterian Hospital.
In addition to his clinical expertise, Dr. Gaudino is currently the Director of Translational and Clinical Research in the Department of Cardiothoracic Surgery. Throughout his academic career, Dr. Gaudino has authored more than 500 peer-reviewed journal articles along with numerous book chapters. He is currently the lead investigator of an international, randomized, controlled trial which aims to determine the optimal strategy for coronary artery bypass surgery (the ROMA trial). He currently serves as the Chair of the Coronary Artery Surgery Task Force of the European Association for Cardio-thoracic Surgery.
Dr. Gaudino’s interests include all aspects of adult cardiac surgery. Along with his expert training and knowledge in coronary artery bypass surgery, including the use of multiple arterial grafting (radial artery conduits, the use of bilateral internal mammary arteries), Dr. Gaudino also specializes in structural heart disease, valvular dysfunction and complex aortic procedures.
Dr. Gaudino also serves as the Director for the Joint Clinical Trials Office (JCTO) at Weill Cornell Medicine and NY-Presbyterian. In his role, Dr. Gaudino oversees ongoing clinical trials and provide strategic growth plans to increase investigator-initiated trials, pragmatic trials, and ongoing improvements and enhancements to the existing clinical trial infrastructure.
REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial
Sunday, January 28, 2024
7:00 AM – 7:12 AM CT
Moderated Panel Discussion and Audience Q&A: RECHARGE Trial
Sunday, January 28, 2024
7:12 AM – 8:00 AM CT
How to Leverage AI for Clinical Research
Sunday, January 28, 2024
3:36 PM – 3:47 PM CT